Now that Facebook’s new commenting policy is forcing every pharmaceutical to rethink it’s Facebook strategy -- ie, take down all disease-specific pages but keep corporate pages -- many drug companies are revising their corporate FB pages.Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the crowd of pharma FB pages by designing colorful a Welcome page and icons (see image below; click on image for enlarged view).
